Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

The efficacy and safety of exogenous melatonin for primary sleep disorders. A meta-analysis.

Buscemi N, Vandermeer B, Hooton N, Pandya R, Tjosvold L, Hartling L, Baker G, Klassen TP, Vohra S.

J Gen Intern Med. 2005 Dec;20(12):1151-8.

2.

Efficacy and safety of exogenous melatonin for secondary sleep disorders and sleep disorders accompanying sleep restriction: meta-analysis.

Buscemi N, Vandermeer B, Hooton N, Pandya R, Tjosvold L, Hartling L, Vohra S, Klassen TP, Baker G.

BMJ. 2006 Feb 18;332(7538):385-93. Epub 2006 Feb 10. Review.

3.

Pharmacotherapies for sleep disturbances in dementia.

McCleery J, Cohen DA, Sharpley AL.

Cochrane Database Syst Rev. 2016 Nov 16;11:CD009178. Review.

PMID:
27851868
4.

Pharmacotherapies for sleep disturbances in Alzheimer's disease.

McCleery J, Cohen DA, Sharpley AL.

Cochrane Database Syst Rev. 2014 Mar 21;(3):CD009178. doi: 10.1002/14651858.CD009178.pub2. Review. Update in: Cochrane Database Syst Rev. 2016 Nov 16;11:CD009178.

PMID:
24659320
5.

Pharmacological interventions for sleepiness and sleep disturbances caused by shift work.

Liira J, Verbeek JH, Costa G, Driscoll TR, Sallinen M, Isotalo LK, Ruotsalainen JH.

Cochrane Database Syst Rev. 2014 Aug 12;(8):CD009776. doi: 10.1002/14651858.CD009776.pub2. Review.

PMID:
25113164
6.

Exogenous melatonin for sleep disorders in neurodegenerative diseases: a meta-analysis of randomized clinical trials.

Zhang W, Chen XY, Su SW, Jia QZ, Ding T, Zhu ZN, Zhang T.

Neurol Sci. 2016 Jan;37(1):57-65. doi: 10.1007/s10072-015-2357-0. Epub 2015 Aug 9.

PMID:
26255301
7.

Meta-analysis: melatonin for the treatment of primary sleep disorders.

Ferracioli-Oda E, Qawasmi A, Bloch MH.

PLoS One. 2013 May 17;8(5):e63773. doi: 10.1371/journal.pone.0063773. Print 2013.

8.

Melatonin Treatment in Children with Developmental Disabilities.

Schwichtenberg AJ, Malow BA.

Sleep Med Clin. 2015 Jun;10(2):181-7. doi: 10.1016/j.jsmc.2015.02.008. Epub 2015 Mar 23. Review.

9.

The use of exogenous melatonin in delayed sleep phase disorder: a meta-analysis.

van Geijlswijk IM, Korzilius HP, Smits MG.

Sleep. 2010 Dec;33(12):1605-14. Review.

10.

Therapeutic effects of melatonin receptor agonists on sleep and comorbid disorders.

Laudon M, Frydman-Marom A.

Int J Mol Sci. 2014 Sep 9;15(9):15924-50. doi: 10.3390/ijms150915924. Review.

11.

The efficacy and safety of drug treatments for chronic insomnia in adults: a meta-analysis of RCTs.

Buscemi N, Vandermeer B, Friesen C, Bialy L, Tubman M, Ospina M, Klassen TP, Witmans M.

J Gen Intern Med. 2007 Sep;22(9):1335-50. Epub 2007 Jul 10.

12.

Systematic reviews of the effectiveness of day care for people with severe mental disorders: (1) acute day hospital versus admission; (2) vocational rehabilitation; (3) day hospital versus outpatient care.

Marshall M, Crowther R, Almaraz-Serrano A, Creed F, Sledge W, Kluiter H, Roberts C, Hill E, Wiersma D, Bond GR, Huxley P, Tyrer P.

Health Technol Assess. 2001;5(21):1-75. Review.

13.

Melatonin for sleep problems in children with neurodevelopmental disorders.

[No authors listed]

Drug Ther Bull. 2015 Oct;53(10):117-20. doi: 10.1136/dtb.2015.10.0358.

PMID:
26471270
14.

Evidence for the efficacy of melatonin in the treatment of primary adult sleep disorders.

Auld F, Maschauer EL, Morrison I, Skene DJ, Riha RL.

Sleep Med Rev. 2017 Aug;34:10-22. doi: 10.1016/j.smrv.2016.06.005. Epub 2016 Jul 20. Review.

PMID:
28648359
15.

Melatonin: therapeutic use in sleep disorders.

Chase JE, Gidal BE.

Ann Pharmacother. 1997 Oct;31(10):1218-26. Review.

PMID:
9337448
16.

Potential of melatonin replacement therapy in older patients with sleep disorders.

Haimov I, Lavie P.

Drugs Aging. 1995 Aug;7(2):75-8. No abstract available.

PMID:
7579785
17.

The use of MElatonin in children with neurodevelopmental disorders and impaired sleep: a randomised, double-blind, placebo-controlled, parallel study (MENDS).

Appleton RE, Jones AP, Gamble C, Williamson PR, Wiggs L, Montgomery P, Sutcliffe A, Barker C, Gringras P.

Health Technol Assess. 2012;16(40):i-239. doi: 10.3310/hta16400.

18.

Melatonin improves sleep in children with epilepsy: a randomized, double-blind, crossover study.

Jain SV, Horn PS, Simakajornboon N, Beebe DW, Holland K, Byars AW, Glauser TA.

Sleep Med. 2015 May;16(5):637-44. doi: 10.1016/j.sleep.2015.01.005. Epub 2015 Jan 21.

19.

Melatonin for sleep in children with autism: a controlled trial examining dose, tolerability, and outcomes.

Malow B, Adkins KW, McGrew SG, Wang L, Goldman SE, Fawkes D, Burnette C.

J Autism Dev Disord. 2012 Aug;42(8):1729-37; author reply 1738. doi: 10.1007/s10803-011-1418-3.

20.

A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer's disease.

Singer C, Tractenberg RE, Kaye J, Schafer K, Gamst A, Grundman M, Thomas R, Thal LJ; Alzheimer's Disease Cooperative Study.

Sleep. 2003 Nov 1;26(7):893-901.

Supplemental Content

Support Center